Abnormal premotor–motor interaction in heterozygous Parkin- and Pink1 mutation carriers

•Asymptomatic heterozygous Parkin/PINK1 mutation carriers show altered premotor–motor inhibition.•A single l-dopa administration could partly reverse this alteration.•These mutation carriers can serve as in vivo models to study pre-symptomatic stages of Parkinsonism. Mutations in the Parkin and PINK...

Full description

Saved in:
Bibliographic Details
Published inClinical neurophysiology Vol. 128; no. 1; pp. 275 - 280
Main Authors Weissbach, Anne, Bäumer, Tobias, Pramstaller, Peter P., Brüggemann, Norbert, Tadic, Vera, Chen, Robert, Klein, Christine, Münchau, Alexander
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•Asymptomatic heterozygous Parkin/PINK1 mutation carriers show altered premotor–motor inhibition.•A single l-dopa administration could partly reverse this alteration.•These mutation carriers can serve as in vivo models to study pre-symptomatic stages of Parkinsonism. Mutations in the Parkin and PINK1 gene account for the majority of autosomal recessive early-onset Parkinson cases. There is increasing evidence that clinically asymptomatic subjects with single heterozygous mutations have a latent nigrostriatal dopaminergic deficit and could be taken as in vivo model of pre-symptomatic phase of Parkinsonism. We charted premotor–motor excitability changes as compensatory mechanisms for subcortical dopamine depletions using transcranial magnetic stimulation by applying magnetic resonance-navigated premotor–motor cortex conditioning in 15 asymptomatic, heterozygous Parkin and PINK1 mutation carriers (2 female; mean age 53±8years) and 16 age- and sex-matched controls (5 female; mean age 57±9years). Participants were examined at baseline and after acute l-dopa challenge. There were l-dopa and group specific effects during premotor–motor conditioning at an interstimulus interval of 6ms indicating a normalisation of premotor–motor interactions in heterozygous Parkin and PINK1 mutation carriers after l-dopa intake. Non-physiologically high conditioned MEP amplitudes at this interval in mutation carriers decreased after l-dopa intake but increased in controls. Premotor–motor excitability changes are part of the cortical reorganization in asymptomatic heterozygous Parkin- and PINK1 mutation carriers. These subjects offer opportunities to delineate motor network adaptation in pre-symptomatic Parkinsonism.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1388-2457
1872-8952
DOI:10.1016/j.clinph.2016.10.007